arotinolol has been researched along with Action Tremor in 5 studies
arotinolol: structure given in first source; arotinolol is the (+-)-isomer
| Excerpt | Relevance | Reference |
|---|---|---|
| "The aim of the present study is to demonstrate the effect of arotinolol on drug-induced tremor in psychiatric patients." | 7.81 | Use of Arotinolol Pharmacotherapy to Treat Drug-induced Tremor: A Report of Three Cases. ( Bahk, WM; Lee, DB; Woo, YS, 2015) |
| "The effect of arotinolol, a peripherally acting beta-adrenergic-blocking agent, on postural or kinetic tremor was studied in monkeys with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced parkinsonism." | 7.68 | Therapeutic effects of arotinolol, a beta-adrenergic blocker, on tremor in MPTP-induced parkinsonian monkeys. ( Kuno, S; Mizuta, E; Nishida, J; Takechi, M, 1992) |
| "We investigated the effect of arotinolol, a new peripherally acting beta-adrenergic blocker, in 15 patients with essential tremor." | 7.67 | Treatment of essential tremor with arotinolol. ( Kakigi, R; Kuroda, Y; Shibasaki, H, 1988) |
| "The aim of the present study is to demonstrate the effect of arotinolol on drug-induced tremor in psychiatric patients." | 3.81 | Use of Arotinolol Pharmacotherapy to Treat Drug-induced Tremor: A Report of Three Cases. ( Bahk, WM; Lee, DB; Woo, YS, 2015) |
| "The effect of arotinolol, a peripherally acting beta-adrenergic-blocking agent, on postural or kinetic tremor was studied in monkeys with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced parkinsonism." | 3.68 | Therapeutic effects of arotinolol, a beta-adrenergic blocker, on tremor in MPTP-induced parkinsonian monkeys. ( Kuno, S; Mizuta, E; Nishida, J; Takechi, M, 1992) |
| "We investigated the effect of arotinolol, a new peripherally acting beta-adrenergic blocker, in 15 patients with essential tremor." | 3.67 | Treatment of essential tremor with arotinolol. ( Kakigi, R; Kuroda, Y; Shibasaki, H, 1988) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (20.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lee, DB | 1 |
| Woo, YS | 1 |
| Bahk, WM | 1 |
| Akiyama, T | 1 |
| Miyahara, H | 1 |
| Waki, K | 1 |
| Yoshinaga, H | 1 |
| Kobayashi, K | 1 |
| Yamashita, S | 1 |
| Maeda, Y | 1 |
| Ohmori, H | 1 |
| Uchida, Y | 1 |
| Hirano, T | 1 |
| Yonemura, K | 1 |
| Uyama, E | 1 |
| Uchino, M | 1 |
| Kuno, S | 1 |
| Mizuta, E | 1 |
| Nishida, J | 1 |
| Takechi, M | 1 |
| Kuroda, Y | 1 |
| Kakigi, R | 1 |
| Shibasaki, H | 1 |
5 other studies available for arotinolol and Action Tremor
| Article | Year |
|---|---|
Use of Arotinolol Pharmacotherapy to Treat Drug-induced Tremor: A Report of Three Cases.
Topics: Aged; Antidepressive Agents; Antipsychotic Agents; Depressive Disorder, Major; Female; Humans; Middl | 2015 |
A Japanese case of hereditary chin trembling responsive to arotinolol.
Topics: Adrenergic Antagonists; Asian People; Child; Female; Humans; Jaw Diseases; Propanolamines; Tremor | 2016 |
Pantothenate kinase-associated neurodegeneration initially presenting as postural tremor alone in a Japanese family with homozygous N245S substitutions in the pantothenate kinase gene.
Topics: Acanthocytes; Adult; Anticonvulsants; Asian People; Asparagine; Basal Ganglia; Brain Mapping; Clonaz | 2004 |
Therapeutic effects of arotinolol, a beta-adrenergic blocker, on tremor in MPTP-induced parkinsonian monkeys.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Adrenergic beta-Antagonists; Animals; Macaca fascicula | 1992 |
Treatment of essential tremor with arotinolol.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Female; Humans; Male; Middle Aged; Propanolamines; Tremor | 1988 |